ABBISKO THERAPEUTICS ANNOUNCES POSITIVE PRELIMINARY PHASE 2 RESULTS WITH LAVENGRATINIB (ABSK061) FOR THE TREATMENT OF ACHONDROPLASIA

Reuters · 3d ago

Please log in to view news